| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2025 | Feb 13, 2025 | CORCEPT THERAPEUTICS INC | Chief Scientific Officer | Sell | 36.3 | -85,176 | -31.71% | ✗ | $5.8M |
| Aug 1, 2024 | Aug 5, 2024 | CORCEPT THERAPEUTICS INC | Chief Scientific Officer | Sell | 37.5 | -34,773 | -22.67% | ✗ | $1.3M |
| Jan 8, 2024 | Jan 12, 2024 | CORCEPT THERAPEUTICS INC | Chief Scientific Officer | Sell | 40.0 | -29,792 | -24.19% | ✗ | $818.1K |
| Aug 14, 2023 | Aug 15, 2023 | CORCEPT THERAPEUTICS INC | Chief Scientific Officer | Sell | 20.0 | -20,455 | -21.85% | ✗ | $631.8K |
| Aug 8, 2023 | Aug 9, 2023 | CORCEPT THERAPEUTICS INC | Chief Scientific Officer | Sell | 40.0 | -29,545 | -23.99% | ✗ | $900.5K |
| Sep 28, 2022 | Sep 30, 2022 | CORCEPT THERAPEUTICS INC | Chief Scientific Officer | Sell | 40.0 | -29,997 | -29.08% | ✗ | $781.1K |
| Jan 26, 2022 | Jan 28, 2022 | CORCEPT THERAPEUTICS INC | Chief Scientific Officer | Sell | 40.0 | -25,350 | -32.30% | ✗ | $435K |
| Jul 14, 2021 | Jul 16, 2021 | CORCEPT THERAPEUTICS INC | Chief Scientific Officer | Sell | 40.0 | -30,482 | -44.19% | ✗ | $627.6K |
| Nov 24, 2020 | Nov 27, 2020 | CORCEPT THERAPEUTICS INC | Chief Scientific Officer | Sell | 40.0 | -31,225 | -62.20% | ✗ | $714.4K |